These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8664385)

  • 1. IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts.
    Tahara H; Lotze MT; Robbins PD; Storkus WJ; Zitvogel L
    Hum Gene Ther; 1995 Dec; 6(12):1607-24. PubMed ID: 8664385
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.
    Zitvogel L; Tahara H; Robbins PD; Storkus WJ; Clarke MR; Nalesnik MA; Lotze MT
    J Immunol; 1995 Aug; 155(3):1393-403. PubMed ID: 7636204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of cancer: a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response.
    Lotze MT; Rubin JT; Carty S; Edington H; Ferson P; Landreneau R; Pippin B; Posner M; Rosenfelder D; Watson C
    Hum Gene Ther; 1994 Jan; 5(1):41-55. PubMed ID: 8155771
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of anti-tumor immunity by injection of fibroblasts genetically engineered to produce IL-12 and to express CD70.
    Douin-Echinard V; Robbins PD; Lotze MT; Favre G; Couderc B
    Adv Exp Med Biol; 1998; 451():353-7. PubMed ID: 10026896
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study.
    Kang WK; Park C; Yoon HL; Kim WS; Yoon SS; Lee MH; Park K; Kim K; Jeong HS; Kim JA; Nam SJ; Yang JH; Son YI; Baek CH; Han J; Ree HJ; Lee ES; Kim SH; Kim DW; Ahn YC; Huh SJ; Choe YH; Lee JH; Park MH; Kong GS; Park EY; Kang YK; Bang YJ; Paik NS; Lee SN; Kim SH; Kim S; Robbins PD; Tahara H; Lotze MT; Park CH
    Hum Gene Ther; 2001 Apr; 12(6):671-84. PubMed ID: 11426466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of interleukin-12 gene-based tumor immunotherapy by the reduced secretion of p40 subunit and the combination with farnesyltransferase inhibitor.
    Jin HT; Youn JI; Kim HJ; Lee JB; Ha SJ; Koh JS; Sung YC
    Hum Gene Ther; 2005 Mar; 16(3):328-38. PubMed ID: 15812228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogene therapy as a treatment for malignant brain tumors in young mice.
    Glick RP; Lichtor T; Lin H; Tarlock K; Cohen EP
    J Neurosurg; 2006 Jul; 105(1 Suppl):65-70. PubMed ID: 16871873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.
    Tahara H; Lotze MT
    Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent antitumor effects of intra-arterial injection of fibroblasts genetically engineered to express IL-12 in liver metastasis model of rat: no additional benefit of using retroviral producer cell.
    Iwazawa T; Chau GY; Mori T; Dookeran KA; Rubin JT; Watkins S; Robbins PD; Lotze MT; Tahara H
    Cancer Gene Ther; 2001 Jan; 8(1):17-22. PubMed ID: 11219489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy.
    Eliopoulos N; Francois M; Boivin MN; Martineau D; Galipeau J
    Cancer Res; 2008 Jun; 68(12):4810-8. PubMed ID: 18559528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancer.
    Elder EM; Lotze MT; Whiteside TL
    Hum Gene Ther; 1996 Mar; 7(4):479-87. PubMed ID: 8800742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
    Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
    Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential immunogene therapy with interleukin-12- and interleukin-15-engineered neuroblastoma cells cures metastatic disease in syngeneic mice.
    Croce M; Meazza R; Orengo AM; Radić L; De Giovanni B; Gambini C; Carlini B; Pistoia V; Mortara L; Accolla RS; Corrias MV; Ferrini S
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):735-42. PubMed ID: 15701863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumoral effect of interleukin-12-secreting fibroblasts in a mouse model of ovarian cancer: implications for the use of ovarian cancer biopsy-derived fibroblasts as a vehicle for regional gene therapy.
    Sanches R; Kuiper M; Penault-Llorca F; Aunoble B; D'Incan C; Bignon YJ
    Cancer Gene Ther; 2000 May; 7(5):707-20. PubMed ID: 10830718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo.
    Tahara H; Zeh HJ; Storkus WJ; Pappo I; Watkins SC; Gubler U; Wolf SF; Robbins PD; Lotze MT
    Cancer Res; 1994 Jan; 54(1):182-9. PubMed ID: 7903204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors.
    Chang CJ; Chen YH; Huang KW; Cheng HW; Chan SF; Tai KF; Hwang LH
    Hepatology; 2007 Mar; 45(3):746-54. PubMed ID: 17326190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose adenoviral immunotherapy of rat hepatocellular carcinoma using single-chain interleukin-12.
    Waehler R; Ittrich H; Mueller L; Krupski G; Ameis D; Schnieders F
    Hum Gene Ther; 2005 Mar; 16(3):307-17. PubMed ID: 15812226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study.
    Sobol RE; Royston I; Fakhrai H; Shawler DL; Carson C; Dorigo O; Gjerset R; Gold DP; Koziol J; Mercola D
    Hum Gene Ther; 1995 Feb; 6(2):195-204. PubMed ID: 7734519
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of combined therapy with interleukin 2 and interleukin 12 gene-transfected tumor vaccine for head and neck carcinoma.
    Kimura Y; Mizuno H; Satake K; Tahara H; Tsukuda M
    Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1181-5. PubMed ID: 14623747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for murine renal cell carcinoma using genetically engineered tumor cells to secrete interleukin-12.
    Kasaoka Y; Nakamoto T; Wang J; Usui T; Hamada H
    Hiroshima J Med Sci; 2000 Mar; 49(1):29-35. PubMed ID: 10824454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.